Urotheelcelcarcinoom - Med-Info

Richtlijn: Urotheelcarcinoom van de blaas (1.0)
Huang GJ, Stein JP. Open radical cystectomy with lymphadenectomy remains the treatment of choice for
invasive bladder cancer. Curr Opin Urol 2007; 17: 369-75.
126 - Huguet J
Huguet J, Monllau V, Sabate S, Rodriguez-Faba O, Algaba F, Palou J, et al. Diagnosis, risk factors, and
outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients. Eur
Urol 2008; 53; 785-93.
127 - Huguet J
Huguet J, Palou J, Serrallach M, Sole Balcells FJ, Salvador J, Villavicencio H. Management of urethral
recurrence in patients with Studer ileal neobladder. Eur Urol 2003: 43: 495-8.
128 - Huncharek M
Huncharek M, Kupelnick B. Impact of intravesical chemotherapy versus BCG immunotherapy on
recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation. Am J Clin
Oncol 2003; 26: 402-7.
129 - Huncharek M
Huncharek M, Muscat J, Geschwind JF. Planned preoperative radiation therapy in muscle invasive bladder
cancer; results of a meta-analysis. Anticancer Research 1998; 18: 1931-4.
130 - Husband JE
Husband JE, Olliff JF, Williams MP, et al. Bladder cancer: staging with CT and MR imaging. Radiology
1989; 173: 435-40.
131 - Int
Int, Collaboration of trialists. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for
muscle-invasive bladder cancer: a randomised contolled trial. Lancet 1999; 354: 533-40.
132 - Itzchak Y
Itzchak Y, Singer D, Fischelovitch Y. Ultrasonographic assessment of bladder tumors. I. Tumor detection. J
Urol 1981; 126: 31-3.
133 - Jager GJ
Jager GJ, Barentsz JO, Oosterhof GO, et al. Pelvic adenopathy in prostatic and urinary bladder carcinoma:
MR imaging with a three-dimensional T1-weighted magnetization-prepared-rapid gradient-echo sequence.
AJR Am J Roentgenol 1996; 167: 1503-7.
134 - Jakse G
Jakse G, Algaba F, Fossa S, Stenzl A, Sternberg C. Guidelines on Bladder Cancer. European Association
of Urology 2006.
135 - Jakse G
Jakse G, Algaba F, Malmstrom PU, Oosterlinck W. A second-lookTURin T1 transitional cell carcinoma:
why? Eur Urol 2004; 45: 539-46.
136 - Jakse G
Jakse G, Algaba F, Fossa S, Stenzel A, Sternberg C. Guidelines on bladder cancer: muscle-invasive and
metastatic. EAU, 2006.
137 - Jakse G
Jakse G, Hall R, Bono A, Höltl W, Carpentier P, Spaander JP, van der Meijden AP, Sylvester R.
Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU
Group phase II protocol 30861. Eur Urol 2001; 40: 144-50.
138 - Jakse G
Jakse G, Hall R, Bono A, Höltl W, Carpentier P, Spaander JP, van der Meijden AP, Sylvester R.
Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU
Group phase II protocol 30861. Eur Urol 2001; 40: 144-50.
09/17/12 Urotheelcarcinoom van de blaas (1.0) 72